Published in Aliment Pharmacol Ther on August 15, 2006
Additional corpus biopsy enhances the detection of Helicobacter pylori infection in a background of gastritis with atrophy. BMC Gastroenterol (2012) 0.96
Performance of Routine Helicobacter pylori Invasive Tests in Patients with Dyspepsia. Gastroenterol Res Pract (2013) 0.81
Dynamic Changes in Helicobacter pylori Status Following Gastric Cancer Surgery. Gut Liver (2016) 0.81
Diagnostic Methods of Helicobacter pylori Infection for Epidemiological Studies: Critical Importance of Indirect Test Validation. Biomed Res Int (2016) 0.78
Evaluation of methods for H. pylori detection in PPI consumption using culture, rapid urease test and smear examination. Ann Transl Med (2015) 0.75
Diagnostic accuracy of the (14)C-urea breath test in Helicobacter pylori infections: a meta-analysis. Wien Klin Wochenschr (2016) 0.75
Feasibility and accuracy of confocal endomicroscopy in comparison with narrow-band imaging and chromoendoscopy for the differentiation of colorectal lesions. Am J Gastroenterol (2012) 2.28
Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects. Am J Clin Nutr (1998) 2.26
Argon plasma coagulation in flexible gastrointestinal endoscopy: pilot experiences. Endoscopy (1997) 2.10
Differential features of gastric cancer patients, either Helicobacter pylori positive or Helicobacter pylori negative. Ital J Gastroenterol Hepatol (1999) 2.02
Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer (2004) 2.00
Nature meets nurture: molecular genetics of gastric cancer. Hum Genet (2009) 1.87
Goblet cell carcinoid of the appendix: a specific type of carcinoma. Histopathology (2007) 1.73
Value of serology (ELISA and immunoblotting) for the diagnosis of Campylobacter pylori infection. Digestion (1989) 1.73
Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy. Eur J Clin Invest (2001) 1.69
Pilot study of probe-based confocal laser endomicroscopy during colonoscopic surveillance of patients with longstanding ulcerative colitis. Endoscopy (2010) 1.68
HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut (1983) 1.65
Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment. Hum Pathol (2000) 1.62
Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection. Aliment Pharmacol Ther (1998) 1.61
Cholecystokinin receptors in human pancreas and gallbladder muscle: a comparative study. Gastroenterology (1996) 1.55
Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines. Br J Cancer (2004) 1.54
An overview of the current diagnosis and recent developments in neuroendocrine tumours of the gastroenteropancreatic tract: the diagnostic approach. Neth J Med (2011) 1.53
Nonulcer dyspepsia in a Dutch working population and Helicobacter pylori. Ulcer history as an explanation of an apparent association. Arch Intern Med (1995) 1.52
Serum gastrin and mucosal somatostatin in Helicobacter pylori-associated gastritis. Scand J Gastroenterol (1995) 1.47
Mucosal prolapse in the pathogenesis of Peutz-Jeghers polyposis. Gut (2006) 1.42
Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis. Gut (2008) 1.41
Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study. Am J Gastroenterol (2011) 1.36
Flexible endoscopic treatment of Zenker's diverticulum: a new approach. Endoscopy (1995) 1.33
Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases. Dig Liver Dis (2005) 1.25
Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis. Gastroenterology (1990) 1.19
Are activity indices helpful in assessing active intestinal inflammation in Crohn's disease? Gut (1989) 1.17
Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer (2006) 1.16
HLA-A and -B antigens in inflammatory bowel disease. Gut (1986) 1.16
Influence of age and Helicobacter pylori infection on serum pepsinogens in healthy blood transfusion donors. Gut (1992) 1.16
Graft transmission of induced and spontaneous post-transcriptional silencing of chitinase genes. Plant J (2001) 1.14
Rage signalling promotes intestinal tumourigenesis. Oncogene (2012) 1.11
Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut (2005) 1.09
Tissue level, activation and cellular localisation of TGF-beta1 and association with survival in gastric cancer patients. Br J Cancer (2007) 1.09
Surgical management of neoplasms of the ampulla of Vater: local resection or pancreatoduodenectomy and prognostic factors for survival. Surgery (2004) 1.09
Narrow-band imaging versus high-definition endoscopy for the diagnosis of neoplasia in ulcerative colitis. Endoscopy (2010) 1.08
Report of an Amsterdam working group on Barrett esophagus. Virchows Arch (2003) 1.08
High resolution endoscopy and the additional value of chromoendoscopy in the evaluation of duodenal adenomatosis in patients with familial adenomatous polyposis. Endoscopy (2009) 1.07
Molecular prognostic factors in adenocarcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol (2006) 1.06
Prevalence, characterisation and clinical profiles of Shiga toxin-producing Escherichia coli in The Netherlands. Clin Microbiol Infect (2008) 1.06
Cancer of the esophagus and gastric cardia: recent advances. Dis Esophagus (2004) 1.06
Mortality and causes of death in Crohn's disease. Review of 50 years' experience in Leiden University Hospital. Gut (1990) 1.04
Epstein-Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesis. J Clin Pathol (2004) 1.04
mTOR in squamous cell carcinoma of the oesophagus: a potential target for molecular therapy? J Clin Pathol (2008) 1.03
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer. Br J Cancer (2006) 1.03
Effect of gluten supplementation in healthy siblings of children with celiac disease. Gastroenterology (1987) 1.03
Relation between IgG and IgA antibody titres against Helicobacter pylori in serum and severity of gastritis in asymptomatic subjects. J Clin Pathol (1994) 1.03
Does jejunal feeding activate exocrine pancreatic secretion? Eur J Clin Invest (1999) 1.02
Peptic ulcer, non-ulcer dyspepsia and irritable bowel syndrome in The Netherlands and Japan. Scand J Gastroenterol Suppl (1993) 1.01
HLA antigen distribution and HLA haplotype segregation in Crohn's disease. Tissue Antigens (1980) 1.01
Adult height in patients with early onset of Crohn's disease. Gut (2002) 0.99
Mucinous cystadenomas in liver: management and origin. Dig Surg (2010) 0.99
Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study. Aliment Pharmacol Ther (1999) 0.98
Cystadenomas with ovarian stroma in liver and pancreas: an evolving concept. Dig Surg (2006) 0.97
Surgery for unusual histopathologic variants of esophageal neoplasms: a report of 23 cases with emphasis on histopathologic characteristics. Ann Surg Oncol (2003) 0.97
Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype. Dig Liver Dis (2007) 0.97
Malignancies in inflammatory bowel disease: fact or fiction? Scand J Gastroenterol Suppl (2002) 0.97
Increased polyp detection using narrow band imaging compared with high resolution endoscopy in patients with hyperplastic polyposis syndrome. Endoscopy (2011) 0.97
Genetic defects underlying Peutz-Jeghers syndrome (PJS) and exclusion of the polarity-associated MARK/Par1 gene family as potential PJS candidates. Clin Genet (2007) 0.94
New classification for probe-based confocal laser endomicroscopy in the colon. Endoscopy (2011) 0.94
Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: comparison of two areas with different risks for stomach cancer. Cancer Epidemiol Biomarkers Prev (1993) 0.94
A non-radioisotopic method for tracing neutrophils in vivo using 5'-bromo-2'-deoxyuridine. Am J Respir Cell Mol Biol (1994) 0.93
STK11 status and intussusception risk in Peutz-Jeghers syndrome. J Med Genet (2006) 0.93
Doppler sonography evaluation of superior mesenteric artery flow to assess Crohn's disease activity: correlation with clinical evaluation, Crohn's disease activity index, and alpha 1-antitrypsin clearance in feces. AJR Am J Roentgenol (1997) 0.92
A tumour with a neuroendocrine and papillary serous component: two or a pair? J Clin Pathol (2002) 0.91
The serological gastric biopsy: a non-endoscopical diagnostic approach in management of the dyspeptic patient: significance for primary care based on a survey of the literature. Scand J Gastroenterol Suppl (2002) 0.91
Routine morphometrical analysis can improve reproducibility of dysplasia grade in Barrett's oesophagus surveillance biopsies. J Clin Pathol (2002) 0.90
MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not. Br J Cancer (2008) 0.90
Fecal lysozyme in assessment of disease activity in inflammatory bowel disease. Dig Dis Sci (1998) 0.90
Risk factors of peptic ulcer disease: different impact of Helicobacter pylori in Dutch and Japanese populations? J Gastroenterol Hepatol (1996) 0.89
Cyclooxygenase-2 mediated regulation of E-cadherin occurs in conventional but not early-onset gastric cancer cell lines. Cell Oncol (2009) 0.89
Faecal parameters in the assessment of activity in inflammatory bowel disease. Scand J Gastroenterol Suppl (1999) 0.89
Comparison of cyclooxygenase 2 expression in adenocarcinomas of the gastric cardia and distal oesophagus. Gut (2003) 0.88
Effect of medium- and long-chain triglycerides on lower esophageal sphincter pressure: role of CCK. Am J Physiol (1998) 0.88
Assessment of plasma fibronectin in Crohn's disease. Hepatogastroenterology (1991) 0.88
Substance P receptor expression in patients with inflammatory bowel disease. Determination by three different techniques, i.e., storage phosphor autoradiography, RT-PCR and immunohistochemistry. Neuropeptides (2007) 0.87
Mucin profiles and potential for malignancy of human colorectal adenomatous polyps. Cancer (1989) 0.87
Low seroprevalence of Helicobacter pylori antibodies in historical sera of patients with Crohn's disease. Scand J Gastroenterol (1997) 0.87
Dose-dependent inhibition of postprandial gallbladder motility and plasma hormone secretion during acute hyperglycemia. Scand J Gastroenterol (1998) 0.86
Surveillance for familial pancreatic cancer. Scand J Gastroenterol Suppl (2003) 0.86
Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients. Dig Liver Dis (2007) 0.86
Experimental model of obstructive, chronic pancreatitis in pigs. Dig Surg (2003) 0.85
Targets for molecular therapy in esophageal squamous cell carcinoma: an immunohistochemical analysis. Dis Esophagus (2009) 0.85
Levels of circulating cellular fibronectin are increased in patients with rheumatoid vasculitis. Clin Exp Rheumatol (1998) 0.85
Cyclin E low molecular weight isoforms occur commonly in early-onset gastric cancer and independently predict survival. J Clin Pathol (2008) 0.85
Early versus late surgical drainage for obstructive pancreatitis in an experimental model. Br J Surg (2007) 0.85
The effect of equicaloric medium-chain and long-chain triglycerides on pancreas enzyme secretion. Clin Physiol Funct Imaging (2002) 0.85
Dose-related effects of motilin on proximal gastrointestinal motility. Aliment Pharmacol Ther (2002) 0.84
Serological parameters in assessment of degree of gastritis in healthy volunteers. Dig Dis Sci (1995) 0.83
The relevance of salicylic acid in the treatment of plaque psoriasis with dithranol creams. Skin Pharmacol (1988) 0.83
Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease. Eur J Gastroenterol Hepatol (1996) 0.83
Outcome of screening endoscopy in common variable immunodeficiency disorder and X-linked agammaglobulinemia. Endoscopy (2013) 0.83
Leukocytes and decreased left-ventricular contractility during endotoxemia in rabbits. Am J Respir Crit Care Med (1997) 0.83
Weekend treatment with 20 and 40 mg omeprazole: effect on intragastric pH, fasting and postprandial serum gastrin, and serum pepsinogens. Gut (1991) 0.83
HLA-DR antigens and phenotypes in Dutch coeliac children and their families. Clin Genet (1985) 0.83
Mucosal prolapse syndrome presenting as rectal polyposis. J Clin Pathol (2009) 0.83